Steroids vs Placebo in Treatment of Tuberculous Lymphadenitis
Launched by FAHAD JAVED AWAN · Jan 23, 2024
Trial Information
Current as of June 22, 2025
Completed
Keywords
ClinConnect Summary
Tuberculosis earliest records date back to the origin of civilization itself and yet still it remains one of the most elusive of the diseases still haunting the human population in the third world. Newer dugs and treatment protocols are still remain a major focus of discussion in the academic circles. Pakistan accounts for around 60% of the cases of tuberculosis in the East Mediterranean with an overall prevalence reaching 376 cases per 100,000 population. With such a high prevalence of the disease, it becomes punitive that robust TB control programs are run with an aim of not only rooting ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Newly diagnosed patients with tuberculosis having painful tuberculous lymphadenopathy
- Exclusion Criteria:
- • 1. Patients with no tuberculous lymphadenopathy.
- • 2. Patients who are already under treatment for tuberculosis.
- • 3. Patient who developed complications due to anti-TB treatment
About Fahad Javed Awan
Fahad Javed Awan is a dedicated clinical trial sponsor focused on advancing medical research through innovative and rigorous study designs. With a commitment to enhancing patient care and outcomes, Mr. Awan leverages extensive expertise in clinical development, regulatory compliance, and operational management. His leadership fosters collaborative partnerships with healthcare professionals and research institutions, ensuring the successful execution of trials across various therapeutic areas. By prioritizing ethical standards and patient safety, Fahad Javed Awan aims to contribute significantly to the advancement of medical knowledge and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rawalpindi, Punjab, Pakistan
Patients applied
Trial Officials
Fahad J Awan, MBBS
Principal Investigator
Pak Emirates Military Hospital
Muhammad Uneeb Ullah, MBBS
Principal Investigator
Pak Emirates Military Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported